We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Zolgensma data

News List

Ousted AveXis execs doctored Zolgensma data themselves fiercepharma
September 26, 2019
Former AveXis CSO Brian Kaspar, in a previous statement from law firm Heuston Hannigan, “categorically denies any wrongdoing,” and said he is “prepared to assert his rights and defend his conduct accordingly.” And contradicting AveXis’ description, he sai
Novartis inspection puts into question who knew what—and when—about Zolgensma data manipulation fiercepharma
August 14, 2019
Novartis, which last week was publicly shamed by the FDA for manipulating data tied to the application of its gene therapy Zolgensma, has said that it launched an investigation in March, as soon as it learned of the issue.
Senate panel launches probe into Novartis' 'reprehensible' response to Zolgensma data irregularities fiercepharma
August 14, 2019
Novartis caught plenty of flack with last week’s revelation that its FDA application for gene therapy Zolgensma contained manipulated data and that the company didn't inform regulators until after its approval. Now it's facing a congressional investigatio